Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
CAS 83891-03-6
56161-73-0
Concern score
Also known as (±)-desmethylfluoxetine · Desmethylfluoxetine · (+/-)-desmethylfluoxetine · (R)-3-Phenyl-3-(4-trifluoromethyl-phenoxy)-propylamine · (R)-Norfluoxetine-d5 (Phenyl-d5) · 3-Phenyl-3-(4-trifluoromethyl-phenoxy)-propylamine
GTPL208 · Nflx · Norfluoxetin · UNII-K8D70XE2F4
We don't have a plain-language description for Norfluoxetine yet.
Recorded functional uses: An active metabolite of fluoxetine
No restrictions found. Norfluoxetine appears in these published regulatory listings.
No graded research studies for Norfluoxetine yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
How often EPA CPDat has listed Norfluoxetine in a product composition. These are source records, not Greenveil catalog products.
Named organisations
2
Typical roles